| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44,003 |
39,840 |
$1.44M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,842 |
14,794 |
$716K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,836 |
4,580 |
$180K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,400 |
1,312 |
$132K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,073 |
1,945 |
$56K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
751 |
715 |
$51K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
331 |
320 |
$44K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,082 |
4,806 |
$42K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
984 |
914 |
$41K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
553 |
480 |
$37K |
| 87634 |
|
501 |
453 |
$33K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
514 |
486 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,034 |
1,940 |
$31K |
| 36415 |
Collection of venous blood by venipuncture |
10,934 |
9,465 |
$30K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
355 |
331 |
$25K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
2,166 |
1,901 |
$22K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
491 |
444 |
$22K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
264 |
256 |
$22K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,143 |
1,063 |
$17K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
232 |
222 |
$17K |
| 90686 |
|
1,811 |
1,707 |
$16K |
| 99215 |
Prolong outpt/office vis |
252 |
212 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
429 |
409 |
$13K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
117 |
105 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
477 |
438 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
287 |
272 |
$4K |
| 90734 |
|
77 |
69 |
$3K |
| 90651 |
|
48 |
43 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
151 |
135 |
$2K |
| 0240U |
|
13 |
13 |
$2K |
| 80053 |
Comprehensive metabolic panel |
140 |
134 |
$2K |
| 85018 |
|
633 |
592 |
$2K |
| 80050 |
General health panel |
28 |
28 |
$1K |
| 81001 |
|
259 |
248 |
$967.18 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
26 |
25 |
$967.16 |
| 90715 |
|
52 |
45 |
$829.84 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$471.28 |
| 80061 |
Lipid panel |
27 |
26 |
$448.96 |
| 90473 |
|
33 |
33 |
$395.01 |
| 81003 |
|
212 |
192 |
$357.98 |
| 84439 |
|
32 |
31 |
$303.58 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
27 |
26 |
$262.56 |
| 90670 |
|
40 |
40 |
$225.12 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
16 |
16 |
$124.28 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
34 |
26 |
$117.07 |
| 90656 |
|
16 |
16 |
$39.72 |
| 36416 |
|
157 |
148 |
$6.34 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
27 |
26 |
$5.14 |
| 90672 |
|
33 |
33 |
$0.00 |